SEC Filings for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.209   -0.011 (-5.00%) Volume: 16.41k 3:33 PM EDT 18-Oct-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)311/13/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)4307/17/2017
424B5Prospectus [Rule 424(b)(5)]2905/10/2017
8-KCurrent report pursuant to Section 13 or 15(d)3405/10/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)4104/14/2017
S-3/A[Amend] Registration statement under Securities Act of 19332404/07/2017
S-3Registration statement under Securities Act of 19332603/21/2017
10-K/A[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]6403/15/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)2101/17/2017
144Notice of proposed sale of securities pursuant to Rule 144112/21/2016
10-KAnnual report pursuant to Section 13 or 15(d)4012/13/2016
123456789101112131415